Impact of the Inspiratory Cortical Control on the Outcome of the Ventilatory Weaning Test in Patients Intubated in Resuscitation
1 other identifier
interventional
70
1 country
1
Brief Summary
In case of respiratory distress, patients are intubated to be connected to an artificial respirator to ensure gas exchanges. Before any ventilatory weaning, a breathing test in spontaneous ventilation under artificial nose is practiced. The patient keeps the endotracheal tube but is no longer assisted by the ventilator. Mortality is markedly increased with the prolongation of the weaning period. Despite the presence of all weaning criteria and the success of a breathing test in spontaneous ventilation under artificial nose, failure of extubation occurs in 20% of patients. Experimental application of an additional inspiratory load in awake healthy subjects causes a compensatory increase in respiratory work to maintain effective ventilation, and the subject does not develop hypoventilation. This respiratory drive to breathe has been demonstrated by quantified electroencephalography in inspiratory load tests in the form of pre-inspiratory negative deflections of low amplitude similar to the potential described during the preparation of the voluntary movement of a limb. These inspiratory pre-motor potentials begin about 2.5 seconds before the start of a movement in the additional motor area. Does the simple and noninvasive analysis of inspiratory cortical control during the spontaneous ventilation breath test under artificial nose predict the outcome of this test as well as weaning at 7 days?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 21, 2017
CompletedFirst Submitted
Initial submission to the registry
September 23, 2017
CompletedFirst Posted
Study publicly available on registry
December 13, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2020
CompletedResults Posted
Study results publicly available
January 7, 2026
CompletedJanuary 7, 2026
January 1, 2026
2.9 years
September 23, 2017
November 19, 2025
January 6, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Magnitude of Inspiratory Premotor Potentials
Amplitude in microvolts of the inspiratory premotor potentials measured during the first 15 minutes of the artificial noses breathing test in patients who successfully passed their ventilatory withdrawal and in patients who failed their withdrawal.
Fifteen minutes
Study Arms (2)
Successful weaning
EXPERIMENTALPatients extubated after the success of the breathing test in spontaneous ventilation under artificial nose and always extubated after seven days.
Failure to wean
EXPERIMENTALPatients who failed the breathing test in spontaneous ventilation under artificial nose and not extubated or patients extubated after the success of the weaning test in spontaneous ventilation under artificial nose but reintubated within seven days.
Interventions
Simplified electroencephalography using three electroencephalogram electrodes and two electro-oculogram electrodes for the measurement of central respiratory control through the inspiratory premotor potentials.
Eligibility Criteria
You may qualify if:
- All intubated-ventilated patients eligible for an artificial nose breathing test in spontaneous ventilation, according to the physician in charge, and to the protocol of the medical resuscitation service and good clinical practice,
- at least 18 years of age;
- intubated-ventilated for at least 24 hours;
- express consent given by patients or "relatives" after clear and fair information on the study.
You may not qualify if:
- Patients are secondarily excluded from the study only if EEG or pressure monitoring are uninterpretable.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
university hospital center of Poitiers
Poitiers, Vienne, 86000, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
Patients were not consecutively recruited due to the limited availability of investigator/research materials followed by the COVID- 19 pandemic. As a result, this study presents only a fraction of the eligible population. PIP methodology is complex and requires EEG recording and sophisticated EEG signal analysis, which was performed off-line in our study.
Results Point of Contact
- Title
- Dr RAULT Christophe
- Organization
- CHU de Poitiers
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 23, 2017
First Posted
December 13, 2017
Study Start
February 21, 2017
Primary Completion
January 30, 2020
Study Completion
July 30, 2020
Last Updated
January 7, 2026
Results First Posted
January 7, 2026
Record last verified: 2026-01